Re: Better Late Than Never



>I saw this trial and there was serious doubts to whether there was actually
>Laetrile in their medications.
>(One doctor tested it for purity and found that it contained no Laetrile at

I'm sure you have a reference for your claim, so I'll wait patiently for it.

Did you notice that "The hazards of amygdalin therapy were evidenced in several
patients by symptoms of cyanide toxicity or by blood cyanide levels approaching
the lethal range."

It was real Laetrile and it caused its most real effect, cyanide poisoning.

>"Ilsa9" <[email protected]> wrote in message
>news:[email protected]
>> >Maybe you could give him some feedback, drop him a line with some
>> >suggestions such as how to include references to back his claims up.
>> >Just to make sure your money is spent in fact, rather than assumptions?
>> >Anth

>> It would be nice if (that URL again:

>> would have a bibliographic reference to the 6 attempted replications of

>> Sloan Laetrile trials. The author of that article, Benjamin Wilson MD,

>> include links to well designed studies which show that Laetrile does not
>> benefit cancer patients and it does cause cyanide toxicity in an

>> %.
>> It is very clear to anyone who reads the abundant literature cited in Dr
>> Wilson's article, that Laetrile has been tested more than a few times. It

>> no assumption that it is a quack method. It is deadly to assume that
>> otherwise.
>> N Engl J Med. 1982 Jan 28;306(4):201-6. Related Articles, Links
>> A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.
>> Moertel CG, Fleming TR, Rubin J, Kvols LK, Sarna G, Koch R, Currie VE,

>> CW, Jones SE, Davignon JP.
>> One hundred seventy-eight patients with cancer were treated with amygdalin
>> (Laetrile) plus a "metabolic therapy" program consisting of diet, enzymes,

>> vitamins. The great majority of these patients were in good general

>> before treatment. None was totally disabled or in preterminal condition.

>> third had not received any previous chemotherapy. The pharmaceutical
>> preparations of amygdalin, the dosage, and the schedule were

>representative of
>> past and present Laetrile practice. No substantive benefit was observed in
>> terms of cure, improvement or stabilization of cancer, improvement of

>> related to cancer, or extension of life span. The hazards of amygdalin

>> were evidenced in several patients by symptoms of cyanide toxicity or by

>> cyanide levels approaching the lethal range. Patients exposed to this

>> should be instructed about the danger of cyanide poisoning, and their

>> cyanide levels should be carefully monitored. Amygdalin (Laetrile) is a

>> drug that is not effective as a cancer treatment.